首页> 外国专利> GLITARY MITOGENIC POLYPEPTIDIC FACTORS, AND ITS PREPARATION PROCESS, MITOGENIC ACTIVITY TEST, DNA SEQUENCES THAT CODE THE FACTORS AND CONSTRUCTIONS OF DNA THAT UNDERSTAND IT, HOST CELLS, PHARMACEUTICAL OR VETERINARY FORMULATIONS, USE OF POLIPEPTIDES, ANTIBODY, AND GENETIC SEQUENCE ENCODING ACTIVITY GLITARY CELL MITOGENICS.

GLITARY MITOGENIC POLYPEPTIDIC FACTORS, AND ITS PREPARATION PROCESS, MITOGENIC ACTIVITY TEST, DNA SEQUENCES THAT CODE THE FACTORS AND CONSTRUCTIONS OF DNA THAT UNDERSTAND IT, HOST CELLS, PHARMACEUTICAL OR VETERINARY FORMULATIONS, USE OF POLIPEPTIDES, ANTIBODY, AND GENETIC SEQUENCE ENCODING ACTIVITY GLITARY CELL MITOGENICS.

机译：军种致突变性多肽因子，其制备过程，致突变活性试验，编码需要理解的DNA的因子和结构的DNA序列，宿主细胞，药物或兽药的配方，胶粒，多肽的使用，多肽。

页面导航

摘要
著录项
相似文献

摘要

The invention provides new Schwann Cell-mitogenic factors of molecular weight 30 to 36 and 55 to 63 kilodaltons, respectively, when isolated by SDS-PAGE. The invention provides therapeutic formulations comprising the new factors, and the use of the factors and those formulations in treating conditions which involve a factor-sensitive or factor-responsive cell type.

机译：当通过SDS-PAGE分离时，本发明提供了分子量分别为30至36和55至63千道尔顿的新的雪旺氏细胞促有丝分裂因子。本发明提供了包含新因子的治疗制剂，以及这些因子和那些制剂在治疗涉及因子敏感或因子应答细胞类型的疾病中的用途。

著录项

公开/公告号PT100344A

专利类型
公开/公告日1993-07-30

原文格式PDF
申请/专利权人 CAMBRIDGE NEUROSCIENCE INC.;LUDWIG INSTITUTE FOR CANCER RESEARCH;
展开▼

申请/专利号PT19920100344
发明设计人 ANDREW DAVID JOHN GOODEARL;MICHAEL DEREK WATERFIELD;PAUL STROOBANT;LUISA MINGHETTI;MARK A MARCHIONNI;
展开▼

申请日1992-04-03
分类号C12P21/00;C12N15/00;
国家 PT
入库时间 2022-08-22 05:10:32

相似文献

专利
外文文献